You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FMS-like tyrosine kinase receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Boston, Massachusetts
  • +2 more
Jan 18, 2023

Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

Recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Gilteritinib Exposure
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Aug 18, 2022

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

sFlt- 1, PIGF, and Niacin Levels in Premature Ovarian

Completed
  • Premature Ovarian Insufficiency
  • ultrasound assessment
  • Gaziantep, Turkey
    Cengiz Gokcek Women's and Child's hospital
Aug 30, 2021

GilteRInf 2022 Study (Gilteritinib Related Infections)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Roma, RM, Italy
    Maria Ilaria Del Principe
Mar 17, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

Available
  • FLT3-ITD Mutation
  • +3 more
  • Crenolanib besylate
  • Genova, Italy
    Ospedale Policlinico San Martino
May 21, 2020

Patterns and Key Healthcare Resource Use in Acute Myeloid

Completed
  • Acute Myeloid Leukemia (AML)
  • Treatment patterns among AML patients
  • AML-related healthcare resources
  • Charlotte, North Carolina
    Sermo
Jan 25, 2022

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • (no location specified)
Oct 18, 2022

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

Recruiting
  • Acute Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 28, 2022

Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

Active, not recruiting
  • Liposarcoma
  • Metastatic Liposarcoma
  • Boston, Massachusetts
  • +2 more
Nov 23, 2022

Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

Active, not recruiting
  • Neoplasm
  • Beijing, China
  • +5 more
Jan 31, 2023

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

    Not yet recruiting
    • Advanced/Metastatic Solid Tumors
    • Frankston, Victoria, Australia
    • +2 more
    Nov 3, 2022

    Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)

    Recruiting
    • Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
    • Topical Timolol
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 14, 2023

    NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • (no location specified)
    Mar 27, 2023

    Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)

    Terminated
    Has Results
    • Rhabdomyosarcoma
    • +2 more
    • Los Angeles, California
    • +1 more
    Mar 17, 2022

    MuSK Myasthenia Gravis Trial (MuSK-CAART)

    Not yet recruiting
    • MuSK Myasthenia Gravis
    • MuSK-CAART
    • (no location specified)
    Jul 5, 2022

    Fetal Growth Retardation, Preeclampsia, Placenta Diseases Trial in Spain (soluble fms-like tyrosine kinase to placental growth

    Not yet recruiting
    • Fetal Growth Retardation
    • +2 more
    • soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF)
    • A Coruña, Spain
    • +23 more
    Mar 17, 2022

    Advanced Non Small Cell Lung Cancer Trial in Changchun, Shanghai, Hangzhou (D-0316)

    Active, not recruiting
    • Advanced Non Small Cell Lung Cancer
    • Changchun, Jilin, China
    • +2 more
    Apr 29, 2022

    Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose

    Active, not recruiting
    • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
    • Beijing, China
    • +47 more
    Aug 17, 2022

    Myasthenia Gravis, MuSK Trial in Cleveland, Philadelphia (Amifampridine Phosphate)

    Active, not recruiting
    • Myasthenia Gravis, MuSK
    • Amifampridine Phosphate
    • Cleveland, Ohio
    • +1 more
    Jul 21, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Midostaurin)

    Completed
    • Acute Myeloid Leukemia
    • Pleven, Bulgaria
    • +85 more
    Feb 11, 2022